International safety notice

Alert 2816 (Technosurveillance) Update Orangelife Action HIV Self-Test Recall of two specific lots determined by RE nº 565, of 02/28/2019, and expansion of the action to new lots.

Brazil / Anvisa · BRA · Mar 14, 2019

Key facts

Title Alert 2816 (Technosurveillance) Update Orangelife Action HIV Self-Test Recall of two specific lots determined by RE nº 565, of 02/28/2019, and expansion of the action to new lots.
Regulator Brazil / Anvisa
Country BRA
Brand Commercial Name: Action Technical Name: Self-test for Human Immunodeficiency Virus (HIV) Antibodies ANVISA registration number: 80535240050 Risk Class: IV Affected presentation: Kit for 1 test Affected serial numbers: 183AHI1023UK;
Manufacturer EMPRESA DETENTORA DO REGISTRO ORANGELIFE COMÉRCIO E INDÚSTRIA CNPJ 09449181000102 ESTRADA DOS BANDEIRANTES 11742 PARTE VARGEM PEQUENA RIO DE JANEIRO RJ TEL 2124421121 EMAIL LARISSAORANGELIFECOMBR FABRICANTE DO PRODUTO ORANGELIFE COMÉRCIO E INDÚSTRIA LTDA ESTRADA DOS BANDEIRANTES 11742 VARGEM PEQUENA RIO DE JANEIRORJ BRASIL
Models 183AHI1028UK, 183AHI1025UK, 183AHI1032UK, 183AHI1031UK, 183AHI1023UK, 183AHI1033UK, 183AHI1038UK, 183AHI1027UK, 183AHI1029UK, 183AHI1039UK, 183AHI1037UK, 183AHI1036UK and 6 more
Date Mar 14, 2019
Regulator page anvisa.gov.br

At a glance

  • No Recall
  • No Field safety notice

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About International device safety notices

Field safety notices, recalls and safety alerts published by about 30 national medical device regulators outside the United States, matched by Orca1 to FDA device data.

Source: National medical device regulators (as listed), compiled by Orca1

Browse all International device safety notices